Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating activities:
Net loss	$ (8,476,000)	$ (1,987,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Deferred taxes	914,000	0
Amortization of stock-based compensation	589,000	566,000
Distributions of earnings from unconsolidated joint ventures	0	260,000
Project abandonment costs	14,036,000	5,000
Equity in net (income) loss of unconsolidated joint ventures	1,937,000	(184,000)
Depreciation and amortization	1,845,000	2,656,000
(Gain) loss on early extinguishment of debt	123,000	(417,000)
Net changes in operating assets and liabilities:
Contracts and accounts receivable	345,000	1,806,000
Due from affiliates	130,000	524,000
Real estate inventories	27,130,000	9,676,000
Other assets	(11,804,000)	(2,343,000)
Accounts payable	(4,006,000)	(18,753,000)
Accrued expenses and other liabilities	(5,462,000)	(4,041,000)
Net cash provided by (used in) operating activities	17,301,000	(12,232,000)
Investing activities:
Purchases of property and equipment	(125,000)	(5,000)
Contributions and advances to unconsolidated joint ventures	(2,057,000)	(1,335,000)
Distributions of capital and repayment of advances from unconsolidated joint ventures	1,100,000	2,562,000
Net cash (used in) provided by investing activities	(1,082,000)	1,222,000
Financing activities:
Borrowings from credit facility	0	30,000,000
Repayments of credit facility	0	(13,500,000)
Repurchases of senior notes	(4,827,000)	(4,512,000)
Repurchases of common stock	(2,233,000)	(1,042,000)
Tax withholding paid on behalf of employees for stock awards	(303,000)	(488,000)
Net cash (used in) provided by financing activities	(7,363,000)	10,458,000
Net increase (decrease) in cash, cash equivalents and restricted cash	8,856,000	(552,000)
Cash, cash equivalents and restricted cash – beginning of period	79,431,000	42,542,000
Cash, cash equivalents and restricted cash – end of period	$ 88,287,000	$ 41,990,000